EATG » R&D

R&D

Media coverage of the 70th World Health Assembly

Intellectual Property Watch news coverage of the 70th World Health Assembly: Intellectual Property Watch: WHO official: Medicines should not be priced at the value of a life “Member governments of…

Expanding access to medicines: what role for transparency?

Transparency” and “accountability” are familiar buzzwords. Like salt and pepper, they pop up on nearly every list of ingredients for sound policy and good governance. But, as Ilona Kickbusch and…

Antimicrobial resistance needs new R&D models, NGOs say

A group of non-governmental organisations organised a side event to the World Health Assembly to discuss the growing issue of antimicrobial resistance, the way to incentivise research and development for…

WHO studies on local pharma production provide key contrasts between China, India

Two new studies published by the World Health Organization provide insight on the production of pharmaceutical products in India and China. According to the studies, China has a substantial local…

WHO, stakeholders take ‘first step’ on fair pricing for medicines

The World Health Organization has concluded a major one-day forum on fair pricing of medicines, bringing a wide range of stakeholders together in Amsterdam and coming up with several possible…

G20: Can the world’s richest economies innovate for global health?

The term “neglected tropical diseases” is on the way out. Instead, global health experts are beginning to favor the less geographically-restricted “neglected poverty-related diseases,” which reflects not only the borderlessness…

TB and antimicrobial resistance – new models of R&D needed

An editorial published in the Bulletin of the World Health Organization reflects on the need for new models of research and development (R&D) for TB and antimicrobial resistance and describes…

EASL launches major new funding initiative

The EASL International Liver Foundation will drive funding to a wide range of initiatives in Research & Development, Education and Public Awareness. In a keynote speech, at the International Liver…

Demands of disease drive vaccine science

Producers aim much R&D at targets such as Ebola and HIV for which no vaccine exists Vaccine research has a long history, dating back to Edward Jenner’s first inoculation against…

Report finds wide gap in pharma companies’ profits and spending on R&D

A new report from Public Citizen, the US-based consumer rights advocacy group, shows that the 20 largest pharmaceutical corporations are spending significantly less on research and development of new medicines…